Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Surgery
Studies conducted at J.C. Ganz et al on surgery recently published
June 22nd, 2009
According to recent research from Bergen, Norway, "Glomus jugulare tumours represent a great therapeutic challenge. Previous papers have documented good results from Gamma Knife surgery (GKS) with these tumours." "However, the relationship between clinical improvement and tumour shrinkage has never been assessed. There were 14 patients, 9 women and 5 men. The mean follow-up period was 28 months (range 6 to 60 months). All the tumours except one were Fisch type D and the mean volume was 14.2 cm(3) (range 3.7-28.4 cm(3)). The mean prescription dose was 13.6 Gy (range 12-16 Gy). None of the tumours have continued to grow. Eight are smaller and 6 unchanged in volume. Two...
Source: Biotech Business Week (2009-06-22)
|
